[1]
M. Kuc-Rajca, T. Pieńkowski, and A. Walaszkowska-Czyż, “The role of lapatinib in HER2-positive breast cancer”, OncoReview, vol. 3, no. 2(10), pp. 104-107, Jun. 2013.